Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: News
Well stated Ron. Longs have seen many different PR firms come and go. Each time we get excited thinking this new firm will be able to tell our story and get the publicity we think our story deserves. Yet, our new firm says our story is not yet sufficiently compelling to tell. We now have a CEO who is articulate and charismatic. IF he is unable to tell our story, we may as well all move to EDIG. And while you mention the BOD lack of contribution, how about asking how many shares have they purchased on the open market. You have to love it when the insiders are buying large quantities with their own money. Bullish indeed. Despite the uncertainties, we do have an unusual story of success. It certainly is a story that has held many of us here for years. One would think, this story would intrigue many new investors. Long term continued growth and success await and maybe, eventually, we achieve stardom. Maybe the story begins in earnest when we go to NASDAQ.
Share
New Message
Please login to post a reply